209 related articles for article (PubMed ID: 31400120)
1. The MLL1 trimeric catalytic complex is a dynamic conformational ensemble stabilized by multiple weak interactions.
Kaustov L; Lemak A; Wu H; Faini M; Fan L; Fang X; Zeng H; Duan S; Allali-Hassani A; Li F; Wei Y; Vedadi M; Aebersold R; Wang Y; Houliston S; Arrowsmith CH
Nucleic Acids Res; 2019 Sep; 47(17):9433-9447. PubMed ID: 31400120
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of nucleosome recognition and modification by MLL methyltransferases.
Xue H; Yao T; Cao M; Zhu G; Li Y; Yuan G; Chen Y; Lei M; Huang J
Nature; 2019 Sep; 573(7774):445-449. PubMed ID: 31485071
[TBL] [Abstract][Full Text] [Related]
3. On the mechanism of multiple lysine methylation by the human mixed lineage leukemia protein-1 (MLL1) core complex.
Patel A; Dharmarajan V; Vought VE; Cosgrove MS
J Biol Chem; 2009 Sep; 284(36):24242-56. PubMed ID: 19556245
[TBL] [Abstract][Full Text] [Related]
4. The internal interaction in RBBP5 regulates assembly and activity of MLL1 methyltransferase complex.
Han J; Li T; Li Y; Li M; Wang X; Peng C; Su C; Li N; Li Y; Xu Y; Chen Y
Nucleic Acids Res; 2019 Nov; 47(19):10426-10438. PubMed ID: 31544921
[TBL] [Abstract][Full Text] [Related]
5. Automethylation activities within the mixed lineage leukemia-1 (MLL1) core complex reveal evidence supporting a "two-active site" model for multiple histone H3 lysine 4 methylation.
Patel A; Vought VE; Swatkoski S; Viggiano S; Howard B; Dharmarajan V; Monteith KE; Kupakuwana G; Namitz KE; Shinsky SA; Cotter RJ; Cosgrove MS
J Biol Chem; 2014 Jan; 289(2):868-84. PubMed ID: 24235145
[TBL] [Abstract][Full Text] [Related]
6. Biochemical reconstitution and phylogenetic comparison of human SET1 family core complexes involved in histone methylation.
Shinsky SA; Monteith KE; Viggiano S; Cosgrove MS
J Biol Chem; 2015 Mar; 290(10):6361-75. PubMed ID: 25561738
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for activity regulation of MLL family methyltransferases.
Li Y; Han J; Zhang Y; Cao F; Liu Z; Li S; Wu J; Hu C; Wang Y; Shuai J; Chen J; Cao L; Li D; Shi P; Tian C; Zhang J; Dou Y; Li G; Chen Y; Lei M
Nature; 2016 Feb; 530(7591):447-52. PubMed ID: 26886794
[TBL] [Abstract][Full Text] [Related]
8. An Ash2L/RbBP5 heterodimer stimulates the MLL1 methyltransferase activity through coordinated substrate interactions with the MLL1 SET domain.
Cao F; Chen Y; Cierpicki T; Liu Y; Basrur V; Lei M; Dou Y
PLoS One; 2010 Nov; 5(11):e14102. PubMed ID: 21124902
[TBL] [Abstract][Full Text] [Related]
9. A non-active-site SET domain surface crucial for the interaction of MLL1 and the RbBP5/Ash2L heterodimer within MLL family core complexes.
Shinsky SA; Hu M; Vought VE; Ng SB; Bamshad MJ; Shendure J; Cosgrove MS
J Mol Biol; 2014 Jun; 426(12):2283-99. PubMed ID: 24680668
[TBL] [Abstract][Full Text] [Related]
10. PAQR3 modulates H3K4 trimethylation by spatial modulation of the regulatory subunits of COMPASS-like complexes in mammalian cells.
Liu C; Zhang Y; Hou Y; Shen L; Li Y; Guo W; Xu D; Liu G; Zhao Z; Man K; Pan Y; Wang Z; Chen Y
Biochem J; 2015 May; 467(3):415-24. PubMed ID: 25706881
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a novel WDR5-binding site that recruits RbBP5 through a conserved motif to enhance methylation of histone H3 lysine 4 by mixed lineage leukemia protein-1.
Odho Z; Southall SM; Wilson JR
J Biol Chem; 2010 Oct; 285(43):32967-32976. PubMed ID: 20716525
[TBL] [Abstract][Full Text] [Related]
12. Regulation of MLL1 H3K4 methyltransferase activity by its core components.
Dou Y; Milne TA; Ruthenburg AJ; Lee S; Lee JW; Verdine GL; Allis CD; Roeder RG
Nat Struct Mol Biol; 2006 Aug; 13(8):713-9. PubMed ID: 16878130
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.
Dharmarajan V; Lee JH; Patel A; Skalnik DG; Cosgrove MS
J Biol Chem; 2012 Aug; 287(33):27275-89. PubMed ID: 22665483
[TBL] [Abstract][Full Text] [Related]
14. WRAD: enabler of the SET1-family of H3K4 methyltransferases.
Ernst P; Vakoc CR
Brief Funct Genomics; 2012 May; 11(3):217-26. PubMed ID: 22652693
[TBL] [Abstract][Full Text] [Related]
15. Structure of WDR5 bound to mixed lineage leukemia protein-1 peptide.
Patel A; Dharmarajan V; Cosgrove MS
J Biol Chem; 2008 Nov; 283(47):32158-61. PubMed ID: 18829459
[TBL] [Abstract][Full Text] [Related]
16. The structure of the RbBP5 β-propeller domain reveals a surface with potential nucleic acid binding sites.
Mittal A; Hobor F; Zhang Y; Martin SR; Gamblin SJ; Ramos A; Wilson JR
Nucleic Acids Res; 2018 Apr; 46(7):3802-3812. PubMed ID: 29897600
[TBL] [Abstract][Full Text] [Related]
17. Evolving Catalytic Properties of the MLL Family SET Domain.
Zhang Y; Mittal A; Reid J; Reich S; Gamblin SJ; Wilson JR
Structure; 2015 Oct; 23(10):1921-1933. PubMed ID: 26320581
[TBL] [Abstract][Full Text] [Related]
18. Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes.
Alicea-Velázquez NL; Shinsky SA; Loh DM; Lee JH; Skalnik DG; Cosgrove MS
J Biol Chem; 2016 Oct; 291(43):22357-22372. PubMed ID: 27563068
[TBL] [Abstract][Full Text] [Related]
19. Unique Role of the WD-40 Repeat Protein 5 (WDR5) Subunit within the Mixed Lineage Leukemia 3 (MLL3) Histone Methyltransferase Complex.
Shinsky SA; Cosgrove MS
J Biol Chem; 2015 Oct; 290(43):25819-33. PubMed ID: 26324722
[TBL] [Abstract][Full Text] [Related]
20. The Development of Inhibitors Targeting the Mixed Lineage Leukemia 1 (MLL1)-WD Repeat Domain 5 Protein (WDR5) Protein- Protein Interaction.
Ye X; Chen G; Jin J; Zhang B; Wang Y; Cai Z; Ye F
Curr Med Chem; 2020; 27(33):5530-5542. PubMed ID: 31132972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
